Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.
about
Small intestinal bacterial overgrowth syndromeThe malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnosesPregnane X receptor as a target for treatment of inflammatory bowel disordersModulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approachRifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.Pain management in patients with inflammatory bowel disease: insights for the clinicianDiarrhoea due to small bowel diseasesRefining small intestinal bacterial overgrowth diagnosis by means of carbohydrate specificity: a proof-of-concept study.Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth.Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth.Small intestinal bacterial overgrowth syndrome in children.Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770.Therapeutic Effects of Low-dose Bismuth Subcitrate on Symptoms and Health-related Quality of Life in Adult Patients with Irritable Bowel Syndrome: A Clinical Trial.Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and infection
P2860
Q24262889-91D5AC5F-EB3B-4371-A2C0-7DD8D09CA960Q26822538-AE1BB2D3-D286-4928-986E-DAA564618951Q26998347-AD63DA21-AA61-40F9-9F07-CB59D414F856Q35870133-3F18FF02-37D1-4689-A2F0-1740CFCDB7D1Q36157264-2426DAE6-1C30-47FA-9D7C-413B26D73857Q36220453-4BD408E1-2787-4DC1-8CCB-5E4238D5196CQ36753443-3577ACBB-4017-4FA7-8C22-5F158F51C162Q36793813-304F05EC-3575-47DA-ACD2-331329E95049Q37284278-F4C35C88-E384-43B8-BABC-0005BD08FBB9Q37303691-D3E2D512-7CCF-4F01-8C1D-6EC1FA2FBE45Q39081757-55E3B453-7236-4C25-97F8-2A8022B9A8C8Q39993304-61762634-CE74-46C6-95CD-94B826FAB637Q42289564-C54F37F2-1F24-409F-ACA7-4AF41A12C497Q43865171-DC7C4526-4EAB-47F5-B2B9-4495DDB62CA0Q54956782-7726FFAB-87C4-4E45-8258-9CDD1F1BD402Q57301725-3284C85B-55E6-4CFF-86F2-03B4B8FF8DC1
P2860
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@ast
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@en
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@nl
type
label
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@ast
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@en
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@nl
prefLabel
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@ast
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@en
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@nl
P2093
P1476
Antibiotic therapy in small in ...... ifaximin versus metronidazole.
@en
P2093
A Gasbarrini
A Santoliquido
D Roccarina
E C Lauritano
E Scarpellini
G Gasbarrini
G Ghirlanda
M Gabrielli
P304
P577
2009-03-01T00:00:00Z